What is the brand name for Insulin Aspart?
The brand name for Insulin Aspart is Novolog.
Novolog
Insulin Aspart is the generic name for the brand-name drug Novolog. It is an insulin used to treat diabetes (rapid mealtime). On the PTCE Top 200 drug list, Insulin Aspart ranks #102 and is one of the most frequently tested endocrine/diabetes medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.
| Generic name | Insulin Aspart |
|---|---|
| Brand name(s) | Novolog |
| Drug class | Insulin |
| Class group | Endocrine/Diabetes |
| Common use | diabetes (rapid mealtime) |
| DEA schedule | Unscheduled |
| Availability | Prescription only (Rx) |
Rapid‑acting insulin used for glycemic control in diabetes (mealtime/bolus insulin).
Insulin Aspart is an Insulin in the Endocrine/Diabetes group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.
No. Insulin Aspart is not a federally controlled substance (it is unscheduled by the DEA).
Aspart is a RAPID mealtime insulin — give about 15 minutes before eating. The exam loves the Novolog vs Novolin (and Humalog) mix-ups.
The brand name for Insulin Aspart is Novolog.
Insulin Aspart is used to treat diabetes (rapid mealtime). Rapid‑acting insulin used for glycemic control in diabetes (mealtime/bolus insulin).
Insulin Aspart is an Insulin (Endocrine/Diabetes group).
No. Insulin Aspart is not a federally controlled substance (it is unscheduled by the DEA).
RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.
Last reviewed June 25, 2026. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).